Histopathological evaluation of female reproductive tract exposed to sustained delivery of DHEA, and DHEA+E

Biomedical Sciences Instrumentation

Volumn 35, Issue , 1999, Pages 79-84

  Nunnery, Michael ^a   Benghuzzi, Hamed ^a   Tucci, Michelle ^a   Zizzi, Todd ^a   Cason, Zelma ^a   England, Barry ^b   Hughes, James ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Bioceramics; DHEA; Estrus cycle; Reproductive tract; Steroids; Sustained delivery system

Indexed keywords

CERAMIC MATERIALS; GYNECOLOGY; HORMONES; IMPLANTS (SURGICAL); MORPHOLOGY; PHOSPHATE MINERALS;

BIOCERAMICS; DEHYDROEPIANDROSTERONE; ESTROGEN;

CONTROLLED DRUG DELIVERY;

BIOMATERIAL; CALCIUM PHOSPHATE; ESTROGEN; LYSINE; PRASTERONE;

ADRENAL GLAND; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; BODY WEIGHT; CELL PROLIFERATION; CERAMIC PROSTHESIS; CERAMICS; CONFERENCE PAPER; CONTROLLED STUDY; DRUG CAPSULE; FEMALE; FEMALE GENITAL SYSTEM; HEART HYPERTROPHY; HEART WEIGHT; HISTOPATHOLOGY; KIDNEY HYPERTROPHY; KIDNEY MASS; NONHUMAN; ORGAN WEIGHT; PAPANICOLAOU TEST; RAT; SPLEEN WEIGHT; SUSTAINED RELEASE FORMULATION;

ANIMALS; CALCIUM PHOSPHATES; CERAMICS; DEHYDROEPIANDROSTERONE; DRUG DELIVERY SYSTEMS; DRUG IMPLANTS; ESTROGENS; FEMALE; GENITALIA, FEMALE; LYSINE; PHOSPHATES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0032958017     PISSN: 00678856     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (29)

1. Labrie C, Flammand M, Belanger A, Labrie F. High bioavailability of dehydroepiandrosterone administered percutaneously in the rat. J Endocrinol 150:S107-118, 1996.
2. Labrie F, Belanger A, Simard J, Luu, The V, Labrie C. DHEA and peripheral androgen and estrogen formation: intracrinlolgy.Ann. N.Y. Acad. Sci. 774:16-18, 1995.
3. Labrie F. Intracrinology. Mol Cell Endocrinol 78(3):C113-8, 1991.
4. Sourla A, Flamand M, Belanger A, Labrie F. Effect of DHEA on vaginal and uterine histomorphology in the rat. J Steroid Biochem. Molec. Biol. 66(3): 137-149, 1998.
5. Sulcova J, Hill M, Hampl R, Starka L. The differences in serum levels of unconjugated dehydroepiandrosterone and its sulfate during age span in normal subjects. J Endocrinol 154:57, 1997.
6. Luo S, Labrie C, Belanger A,Labrie F. Effect of DHEA on bone mass, serum lipids, and DMBA induced mammary carcinoma in the rat. Endocrinol 138:3387-3394, 1997.
7. Diamond P, Cusan L, Gomez JL, Belanger A, Labrie F. Metabolic effects of 12 month percutaneous DHEA replacement therapy in postmenopausal women. J Endocrinol 150:S43-S50, 1996.
8. Derksen R. Dehydroepiandrosterone (DHEA) and systemic lupus erythematosus. Semin Arthritis Rheum 27(6):335-47, 1998.
9. van Vollenhoven R, Morabito L, Engleman E, McGuire J. Treatment of systemic lupus erythematosus with dehydroepiandrosterone: 50 patients treated up yo 12 months. J Rheumatol 25(2):285-9, 1998.
10. Cleary M. The antiobesity effect of dehydroepiandrosterone in rats. Proc Soc Exper Biol Med 196: S-16, 1991.
11. Clore J. DHEA and body fat. Obes Res 3S4:613S-616S, 1995.
12. Barrou Z, Charru P, Lidy C. Actions of dehydroepiandrosterone: possible links with aging. Presse Med 25(38):1885-9, 1996.
13. Watson R, Huls A, Araghinikuam M, Chung S. Dehydroepiandrosterone and diseases of aging. Drugs Aging 9(4):274-91, 1996.
14. Labrie F, Diamond P, Cusan L, Gomez J, Belanger A. Effect of 12-month DHEA replacement therapy on bone, vagina, and endometrium in postmenopausal women. J Clin Endocrinol Metab 82(10):3498-505, 1997.
15. McCormick D, Rao K, Johnson W, Bowman-Gram T, Steele V, Lubet R, Kelloff G. Exceptional chemopreventive activity of low-dose DHEA in the rat mammary gland. Cancer Research 56:1724-1726, 1996.
16. Luo S, Sourla A, Labrie C, Belanger A, Labrie F. Combined effects of DHEA and EM-800 on bone mass, serum lipids, and the development of DMBA-induced mammary carcinoma in the rat. Endocrinol 138:4435-4444, 1997.
17. Brignardello E, Cassoni P, Migliardi M, Pizzini A, Di Monaco, Bocuzzi G, Massobrio M. DHEA concentration in breast cancer tissue is related to its plasma gradient across the mammary gland. Breast Cancer Research and Treatment 33:171-177, 1995.
18. Dorgan J, Stanczyk F, Longcope C, Stephenson H, Chang L, Miller R, Franz C, Falk R, Kahle L. Relationship of serum DHEA, DHEAS, and ADIOL to breast cancer in postmenopausal women. Cancer Epidemiology, Biomarkers & Prevention 6:177-181, 1997.
19. Schwartz A, Pashko L. Mechanism of cancer preventive action of DHEA, Role of glucose 6 phosphatase dehydrogenase. Annals of the New York Academy of Science 774:180-6, 1995.
20. Muscarella P, Boros L, Fisher W, Rink C, Melvin W. Oral dehydroepiandrosterone inhibits the growth of human pancreatic cancer in nude mice. J Surg Res 79(2): 154-7, 1998.
21. Schulz S, Nyce J. Inhibition of protein isoprenylation and p21ras membrane association by dehydroepiandrosterone in human colonic adenocarcinoma cells in vitro. Cancer Res 51(24):6563-7, 1991.
22. Di Monaco M, Pizzini A, Gatto V, Leonardi L, Gallo M, Brignardello E, Boccuzzi G. Role of G6PD inhibition in the antiproliferative effects of DHEA on human breast cancer cells. British J Cancer 75(4):589-92, 1997.
23. Sourla A, Martel C, Labrie C, Labrie F. Almost exclusive androgenic action of dehydroepiandrosterone in the rat mammary gland. Endocrinol 139(2):753-64, 1998.
24. Svec F, Porter J. The actions of exogenous DHEA in experimental animals and humans. Soc Exper Biol and Med 218:174-91, 1998.
25. Benghuzzi H, Bajpai P. Ceramic drug delivery systems for long term delivery of chemicals and biologicals. J. Biomed Mater Res 22:1245-1266, 1988.
26. Benghuzzi H, Babaro R, Bajpai P. Continued and sustained release of AZT in vitro from TCP drug delivery systems. Biomedical Sciences instrumentation 25:169-177, 1990.
27. Benghuzzi H, England B, Bajpai P. Sustained release of norepinephrine by means of ceramic drug delivery devices. Tenth Southern Biomedical Engineering Conference, Oct 18-21:122-124, 1991.
28. van Weerden W, Bierings H, van Streenbrugge G, de Jong F, Schroder F. Adrenal glands of the mouse and rat do not synthesize androgens. Life Sci 50(12):857-61, 1992.
29. Parker C, Conway-Myers B. The effects of Dehydroepiandrosterone (DHEA on the thymus, spleen, and adrenals of prepubertal and adult female rats. Endocrine Res 24(2):113-126, 1998.